122 related articles for article (PubMed ID: 25451646)
21. CalDAG-GEFI and platelet activation.
Stefanini L; Bergmeier W
Platelets; 2010; 21(4):239-43. PubMed ID: 20218908
[TBL] [Abstract][Full Text] [Related]
22. Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.
Eto K; Murphy R; Kerrigan SW; Bertoni A; Stuhlmann H; Nakano T; Leavitt AD; Shattil SJ
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12819-24. PubMed ID: 12239348
[TBL] [Abstract][Full Text] [Related]
23. Two novel, putative mechanisms of action for citalopram-induced platelet inhibition.
Roweth HG; Cook AA; Moroi M; Bonna AM; Jung SM; Bergmeier W; Sage SO; Jarvis GE
Sci Rep; 2018 Nov; 8(1):16677. PubMed ID: 30420683
[TBL] [Abstract][Full Text] [Related]
24. RASA3 is a critical inhibitor of RAP1-dependent platelet activation.
Stefanini L; Paul DS; Robledo RF; Chan ER; Getz TM; Campbell RA; Kechele DO; Casari C; Piatt R; Caron KM; Mackman N; Weyrich AS; Parrott MC; Boulaftali Y; Adams MD; Peters LL; Bergmeier W
J Clin Invest; 2015 Apr; 125(4):1419-32. PubMed ID: 25705885
[TBL] [Abstract][Full Text] [Related]
25. Guanine nucleotide exchange factors CalDAG-GEFI and CalDAG-GEFII are colocalized in striatal projection neurons.
Toki S; Kawasaki H; Tashiro N; Housman DE; Graybiel AM
J Comp Neurol; 2001 Sep; 437(4):398-407. PubMed ID: 11503142
[TBL] [Abstract][Full Text] [Related]
26. Characterization of RasGRP2, a plasma membrane-targeted, dual specificity Ras/Rap exchange factor.
Clyde-Smith J; Silins G; Gartside M; Grimmond S; Etheridge M; Apolloni A; Hayward N; Hancock JF
J Biol Chem; 2000 Oct; 275(41):32260-7. PubMed ID: 10918068
[TBL] [Abstract][Full Text] [Related]
27. CalDAG-GEFI Deficiency in a Family with Symptomatic Heterozygous and Homozygous Carriers of a Likely Pathogenic Variant in
Morais S; Pereira M; Lau C; Gonçalves A; Monteiro C; Gonçalves M; Oliveira J; Moreira L; Cruz E; Santos R; Lima M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830306
[No Abstract] [Full Text] [Related]
28. CalDAG-GEFIII activation of Ras, R-ras, and Rap1.
Yamashita S; Mochizuki N; Ohba Y; Tobiume M; Okada Y; Sawa H; Nagashima K; Matsuda M
J Biol Chem; 2000 Aug; 275(33):25488-93. PubMed ID: 10835426
[TBL] [Abstract][Full Text] [Related]
29. RAP1-GTPase signaling and platelet function.
Stefanini L; Bergmeier W
J Mol Med (Berl); 2016 Jan; 94(1):13-9. PubMed ID: 26423530
[TBL] [Abstract][Full Text] [Related]
30. Phenotype analysis and clinical management in a large family with a novel truncating mutation in
Desai A; Bergmeier W; Canault M; Alessi MC; Paul DS; Nurden P; Pillois X; Jy W; Ahn YS; Nurden AT
Res Pract Thromb Haemost; 2017 Jul; 1(1):128-133. PubMed ID: 30046681
[TBL] [Abstract][Full Text] [Related]
31. Calcium diacylglycerol guanine nucleotide exchange factor I (CalDAG-GEFI) gene mutations in a thrombopathic Simmental calf.
Boudreaux MK; Schmutz SM; French PS
Vet Pathol; 2007 Nov; 44(6):932-5. PubMed ID: 18039909
[TBL] [Abstract][Full Text] [Related]
32. Essential role for Rap1 GTPase and its guanine exchange factor CalDAG-GEFI in LFA-1 but not VLA-4 integrin mediated human T-cell adhesion.
Ghandour H; Cullere X; Alvarez A; Luscinskas FW; Mayadas TN
Blood; 2007 Nov; 110(10):3682-90. PubMed ID: 17702895
[TBL] [Abstract][Full Text] [Related]
33. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
34. CalDAG-GEFI deficiency protects mice from FcγRIIa-mediated thrombotic thrombocytopenia induced by CD40L and β2GPI immune complexes.
Amirkhosravi A; Boulaftali Y; Robles-Carrillo L; Meyer T; McKenzie SE; Francis JL; Bergmeier W
J Thromb Haemost; 2014 Dec; 12(12):2113-9. PubMed ID: 25287077
[TBL] [Abstract][Full Text] [Related]
35. Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis.
Carbo C; Duerschmied D; Goerge T; Hattori H; Sakai J; Cifuni SM; White GC; Chrzanowska-Wodnicka M; Luo HR; Wagner DD
J Leukoc Biol; 2010 Aug; 88(2):313-9. PubMed ID: 20413728
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
Wang WY; Hsieh PW; Wu YC; Wu CC
Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
[TBL] [Abstract][Full Text] [Related]
37. Identification of two novel mutations in RASGRP2 affecting platelet CalDAG-GEFI expression and function in patients with bleeding diathesis.
Sevivas T; Bastida JM; Paul DS; Caparros E; Palma-Barqueros V; Coucelo M; Marques D; Ferrer-Marín F; González-Porras JR; Vicente V; Hernández-Rivas JM; Watson SP; Lozano ML; Bergmeier W; Rivera J
Platelets; 2018 Mar; 29(2):192-195. PubMed ID: 28762304
[TBL] [Abstract][Full Text] [Related]
38. Activation of the Rap1 guanine nucleotide exchange gene, CalDAG-GEF I, in BXH-2 murine myeloid leukemia.
Dupuy AJ; Morgan K; von Lintig FC; Shen H; Acar H; Hasz DE; Jenkins NA; Copeland NG; Boss GR; Largaespada DA
J Biol Chem; 2001 Apr; 276(15):11804-11. PubMed ID: 11278453
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the gene encoding calcium and diacylglycerol regulated guanine nucleotide exchange factor I (CalDAG-GEFI) in human patients with congenital qualitative platelet disorders.
Puetz J; Boudreaux MK
Platelets; 2012; 23(5):401-3. PubMed ID: 21815871
[No Abstract] [Full Text] [Related]
40. The Guanine-Nucleotide Exchange Factor Caldag Gefi Fine-Tunes Functional Properties of Regulatory T Cells.
Niemz J; Kliche S; Pils MC; Morrison E; Manns A; Freund C; Crittenden JR; Graybiel AM; Galla M; Jänsch L; Huehn J
Eur J Microbiol Immunol (Bp); 2017 Jun; 7(2):112-126. PubMed ID: 28690878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]